MediPharm Labs Corp. shares T.LABS are trading up $0.01 at $0.08.

MediPharm Labs says this product provides patients with a smoke-free option when seeking fast onset of effects without combustion or heating.

MediPharm Labs (TSX:LABS) has commenced production for its novel cannabis metered dose inhalers (MDIs) tailored for the ...

The companion animal drugs market is estimated to reach USD 16,131.2 million in 2024. It is estimated that revenue will increase at a CAGR of 6.2% between 2024 and 2034. The industry is anticipated to ...

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

Inhaled therapeutics is an area of the pharmaceutical industry that is in high demand and is set for continued growth in the ...

CHENNAI: The healthcare industry is increasingly integrating sustainability into its core strategies, with a growing emphasis on reducing environmental footprin ...

Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol ...

Lupin announced today its plan to use Honeywell's Solstice Air (HFO-1234ze cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for patients ...

Lupin partners with Honeywell to revolutionise respiratory care with eco-friendly propellant, reducing greenhouse gas ...

Mumbai: Global pharma major Lupin Limited has announced its plan to use Honeywell's Solstice Air (HFO-1234ze cGMP) propellant ...

Lupin and Honeywell team-up to develop HFO technology in inhalers: Our Bureau, Bengaluru Tuesday, May 20, 2025, 14:15 Hrs [IST] Global pharma major Lupin has firmed up its plan to ...